Cannabis Market Extends Across Numerous Industry Segments
DENVER October 3 2017 PRNewswire Growth has been the dominant theme in the cannabis market. Estimates by Forbes put the legal cannabis market at a value of $7.2 billion per a February 2017 report and...
View ArticleDiplomat Specialty Pharmacy and BHRT AntiAging Network Ageology Form...
FLINT Mich. March 1 2012 PRNewswire In an effort to put Chicago on the map as the healthiest city in the United States&160;Diplomat&160;Specialty&160;Pharmacy the nation's largest privately...
View ArticleNimbus Therapeutics and Celgene Enter LongTerm Strategic Immunology Alliance...
Programs in the alliance are focused on Tyk2 and STING antagonist targets potential drivers of a wide array of autoimmune disorders Nimbus Therapeutics a biotechnology company applying deep...
View ArticleRedHill Biopharma Announces Positive TopLine Results from Phase II Study of...
BEKINDAÂi 12 mg Phase II study successfully met its primary endpoint improving primary efficacy outcome of stool consistency by an absolute difference of 19.4 vs. placebo and comparing favorably with...
View ArticleCNA Finance Provides Research Report On Vitality Biopharma
CNA Finance provides research coverage on Vitality Biopharma; a company focused on achieving growth by building its proprietary portfolio of cannabinoid prodrugs THC based compounds and an intellectual...
View ArticleRedHill Biopharma Announces Positive TopLine Results from Phase II Study of...
BEKINDAÂiÂ12 mg Phase II study successfully met its primary endpoint improving primary efficacy outcome of stool consistency by an absolute difference of 19.4 vs. placebo and comparing favorably with...
View ArticleCatholic Missionary Suing Government Willing to Risk Health Over HHS Mandate
DENVER March 6 2012 PRNewswire A missionary with FOCUS the Fellowship of Catholic University Students and one of two private citizens who has joined states senators and others in a lawsuit against the...
View ArticlePharmspective Publishes White Paper Health Care Reform and the Reshaping of...
NEW YORK March 8 2012 PRNewswire &160;Pharmspective LLC today released the white paper Health Care Reform and the Reshaping of the Pharmaceutical Selling Model forecasting how health care reform...
View ArticleResearchers Discover Five Genetic Variations Associated with Crohn's Disease...
MANHASSET N.Y. March 9 2012 PRNewswireUSNewswire &160;A collaborative group of investigators has joined together to identify five genetic variations associated with Crohn's disease CD and Jewish...
View ArticleNektar Consolidates Research at Its StateoftheArt R&D Center Located in San...
SAN FRANCISCO March 20 2012 PRNewswire Nektar Therapeutics NASDAQNKTR today announced that the company is consolidating its U.S.based research scientists at the company's existing San Francisco...
View ArticleLegislation May Improve Patient Access to Vital Medications
High OutofPocket Costs a Barrier to Health ATLANTA March 20 2012 PRNewswireUSNewswire &160;Costsharing practices that limit access to vital medications for people with serious health conditions may...
View ArticlePharmspective Releases Rheumatoid Arthritis Adoption Insights Report
NEW YORK March 21 2012 PRNewswire Pharmspective LLC today announced&160; the release of its first syndicated report &8211; Rheumatoid Arthritis Adoption Insights. Pharmspective&8482; is a...
View ArticleNektar Reports that Partner Affymax Has Announced FDA Approval of OMONTYSÂ...
SAN FRANCISCO March 28 2012 PRNewswire Nektar Therapeutics NASDAQ NKTR today reported that its partner Affymax Inc. announced that the U.S. Food and Drug Administration FDA has approved...
View ArticlePreexisting Conditions Rise In U.S. Patient Care Remains Inconsistent...
NEW YORK Oct. 4 2017 PRNewswire A new global healthcare report finds that an astonishing 62.5 percent of U.S. adults have been diagnosed with a condition that could be termed "preexisting" for future...
View ArticleChemoCentryx Announces 2011 Fourth Quarter and Full Year Financial Results
MOUNTAIN VIEW Calif. March 30 2012 PRNewswire ChemoCentryx Inc. NASDAQ CCXI announced today its financial results for the fourth quarter and year ended December 31 2011. Net income for the fourth...
View ArticleInDex Pharmaceuticals Holding AB INDEX Pharmaceuticals Healthcare Deals and...
SummaryInDex Pharmaceuticals Holding AB InDex Pharmaceuticals is a pharmaceutical development company that offers treatments for immunological diseases. The company provides lead compound kappaproct...
View ArticleIntegrin Beta 7 Gut Homing Receptor Beta Subunit or ITGB7 Pipeline Review H2...
Integrin Beta 7 Gut Homing Receptor Beta Subunit or ITGB7 Pipeline Review H2 2017SummaryIntegrin Beta 7 Gut Homing Receptor Beta Subunit or ITGB7 pipeline Target constitutes close to 6 molecules. Out...
View ArticleToll Like Receptor 4 hToll or CD284 or TLR4 Pipeline Review H2 2017 Report...
Toll Like Receptor 4 hToll or CD284 or TLR4 Pipeline Review H2 2017SummaryToll Like Receptor 4 hToll or CD284 or TLR4 Tolllike receptor 4 is a protein encoded by the TLR4 gene. This receptor is mostly...
View ArticleAntifungals and probiotics may play a key role in the development of...
Scientists have determined that fungus may play a key role in chronic intestinal inflammation disorders. They found that patients with Crohn's disease tend to have much higher levels of the fungus...
View Article